Kathleen A. Gilmartin - Nov 10, 2023 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: Director
Signature: /s/ Kathleen A Gilmartin
Stock symbol: USPH
Transactions as of: Nov 10, 2023
Transactions value $: $82,340
Form type: 4
Date filed: 11/13/2023, 07:09 PM
Previous filing: May 18, 2023
Next filing: May 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Purchase	$82.3K	+1K	+6.91%	$82.34	15.5K	Nov 10, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $82.32 to $82.35 per share both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of it shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 800 shares of restricted stock granted under the Company equity plans. Restrictions lapse as to 400 shares lapsed on each of January 1, 2024 and April 1, 2023, if she is a director of the Company on those dates.

Content

The price reported is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $82.32 to $82.35 per share both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of it shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Includes 800 shares of restricted stock granted under the Company equity plans. Restrictions lapse as to 400 shares lapsed on each of January 1, 2024 and April 1, 2023, if she is a director of the Company on those dates.